Overview

Salicylic Augmentation in Depression

Status:
Recruiting
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
The investigators are doing this research study to find out if using aspirin along with antidepressant treatment can lessen symptoms of depression. This study also aims to find out if some people improve more from taking aspirin than others. The investigators also want to see if it is possible to predict which participants will do better based on a blood test. Aspirin is approved by the U.S. Food and Drug Administration (FDA) as an over-the-counter pain medication. But, aspirin is not approved by the FDA to make antidepressant treatment better. This research study will compare aspirin to placebo.
Phase:
Phase 2
Details
Lead Sponsor:
Jessica Harder
Jessica Harder, MD
Collaborator:
Columbia University
Treatments:
Aspirin
Salicylates
Salicylic Acid